Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa (Q33756251)

29 July 2017

title

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa (English)

1 reference

29 July 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

Marsden CD

1 reference

29 July 2017

J. D. Parkes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1036999

16 August 2022

A. G. Debono

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1036999

16 August 2022

C. D. Marsden

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1036999

16 August 2022

language of work or name

English

0 references

publication date

1 November 1976

1 reference

full work available at URL

29 July 2017

https://europepmc.org/articles/PMC1083310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1036999

https://europepmc.org/articles/PMC1083310?pdf=render

16 August 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1036999

Journal of Neurology, Neurosurgery and Psychiatry

16 August 2022

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

1101-1108

1 reference

Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Bromocriptine in Parkinsonism.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Metoclopramide and dopamine receptor blockade

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

Dopamine is an important neurotransmitter in the autonomic nervous system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083310

A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

21 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1036999

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1036999

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1036999

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP.39.11.1101

1 reference

29 July 2017

1 reference

29 July 2017

1 reference